{"url":"https://lda.senate.gov/api/v1/filings/ee4638c1-b3b2-44e4-9e9a-59cd29b9196c/","filing_uuid":"ee4638c1-b3b2-44e4-9e9a-59cd29b9196c","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2008,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/ee4638c1-b3b2-44e4-9e9a-59cd29b9196c/print/","filing_document_content_type":"text/html","income":"15000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"William Carney, Director","dt_posted":"2008-07-21T19:02:36-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"505 Capitol Court, NE","registrant_address_2":"Suite 200","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20002","registrant":{"id":8327,"url":"https://lda.senate.gov/api/v1/registrants/8327/","house_registrant_id":32030,"name":"BILL CARNEY AND COMPANY","description":"Public Affairs Consultant","address_1":"505 Capitol Court, NE","address_2":"Suite 200","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20002","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BARBARA CARNEY","contact_telephone":"+1 202-544-8195","dt_updated":"2022-04-06T16:06:47.425997-04:00"},"client":{"id":111718,"url":"https://lda.senate.gov/api/v1/clients/111718/","client_id":152,"name":"GEONUCLIDES, INC.","general_description":"Research and development of medical isotopes","client_government_entity":false,"client_self_select":false,"state":"MO","state_display":"Missouri","country":"US","country_display":"United States of America","ppb_state":"MO","ppb_state_display":"Missouri","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-05-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"U-233 processing at ORNL and potential funding opportunities of the process","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33402,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"CARNEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"U-233 processing at ORNL and potential funding opportunities of the process","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33402,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"CARNEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}